Abstract
Germline allele specific expression (ASE), resulting in a lowered expression of one of the BRCA1 alleles, has been described as a possible predisposition marker in Hereditary Breast or Ovarian Cancer (HBOC), usable for molecular diagnosis in HBOC. The main objective of this prospective case–control study was to compare the proportion of ASE between controls without familial history of breast or ovarian cancer, and HBOC cases without BRCA1 or BRCA2 deleterious mutation. BRCA1 ASE evaluated on three SNPs among controls and HBOC patients without deleterious mutation were assessed by pyrosequencing. The allelic ratios and the proportion of ASE were compared between controls and cases using a Student’s t test and a Fisher exact test, respectively. The linearity and reproducibility of the ASE dosage was demonstrated with R2 > 0.99 and a coefficient of variation below 10 %, and ASE was detected in two positive controls harbouring BRCA1 truncated mutations. In the heterozygote population, composed of 99/264 controls (37.5 %) and 96/227 patients (42.3 %), we detected a 5 % ASE without truncated mutations, in each population. We failed to detect any significant difference of ASE between controls and patients. So far, BRCA1 Allelic specific expression is not usable in routine diagnosis as a possible predisposition marker in HBOC patients except for the detection of truncated mutations.
This is a preview of subscription content, log in via an institution to check access.
References
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792
Chen X, Weaver J, Bove BA, Vanderveer LA, Weil SC, Miron A et al (2008) Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. Hum Mol Genet 17(9):1336–1348
Shen J, Medico L, Zhao H (2011) Allelic imbalance in BRCA1 and BRCA2 gene expression and familial ovarian cancer. Cancer Epidemiol Biomark Prev 20(1):50–56
Caux-Moncoutier V, Pages-Berhouet S, Michaux D, Asselain B, Castera L, De PA et al (2009) Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study. Eur J Hum Genet 17(11):1471–1480
Castera L, Krieger S, Rousselin A, Legros A, Baumann JJ, Bruet O et al (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22(11):1305–1313
Tomsic J, Guda K, Liyanarachchi S, Hampel H, Natale L, Markowitz SD et al (2010) Allele-specific expression of TGFBR1 in colon cancer patients. Carcinogenesis 31(10):1800–1804
Guda K, Natale L, Lutterbaugh J, Wiesner GL, Lewis S, Tanner SM et al (2009) Infrequent detection of germline allele-specific expression of TGFBR1 in lymphoblasts and tissues of colon cancer patients. Cancer Res 69(12):4959–4961
Segui N, Stevens KN, Guino E, Rozek LS, Moreno VR, Capella G et al (2011) No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations. Br J Cancer 104(4):735–740
Abadie C, Killian A, Tinat J, Bougeard M, Medhaoui D, Cailleux AF et al (2011) Allelic imbalance of the TGFbetaR1 is not a major contributor to the genetic predisposition to colorectal cancer. Br J Cancer 104(9):1517–1518
Acknowledgements
We thank Annick Rossi for her contribution; Mario Tosi for advice; and Jean-Jacques Baumann and Agnès Hardouin for their active contributions; Agnès Batho and the numerous volunteers for providing blood control samples; and the Ligue Régionale du Cancer comité du Calvados for funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Additional information
Estelle Jamard and Bertrand Volard have contributed equally to this article.
Rights and permissions
About this article
Cite this article
Jamard, E., Volard, B., Dugué, A.E. et al. BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer. Familial Cancer 16, 167–171 (2017). https://doi.org/10.1007/s10689-016-9940-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-016-9940-2